Leiden University
Records under this name other than the patents Leiden University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,450,321 | Novel [1,2,3]triazolo[4,5-d]pyrimidine Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,457,685 | [1,2,3]triazolo[4,5-d]pyrimidine Derivatives with Affinity for the TYPE-2 Cannabinoid Receptor Formerly held In force · High confidence | In force | High confidence | |
| US 9,644,240 | Disease susceptibility Formerly held Lapsed on the fee record Ended May 9, 2025 · USPTO record | Lapsed on the fee record | Ended May 9, 2025 | USPTO record |
| US 9,290,531 | Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections Formerly held Lapsed on the fee record Ended Mar 22, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 22, 2024 | USPTO record |
| US 8,609,610 | Inhibitors of the trypsin-like site of the proteasome and methods of use thereof Lapsed on the fee record Ended Dec 17, 2021 · USPTO record | Lapsed on the fee record | Ended Dec 17, 2021 | USPTO record |
| US 8,455,431 | Inhibitors of the trypsin-like site of the proteasome and methods of use thereof Lapsed on the fee record Ended Jun 4, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 4, 2021 | USPTO record |
| US 6,485,960 | Polycystic kidney disease 1 gene and uses thereof Formerly held Term ended Term ended Nov 26, 2019 · USPTO record | Term ended | Term ended Nov 26, 2019 | USPTO record |
| US 6,232,452 | Tuberous sclerosis 2 gene and uses thereof Formerly held Term ended Term ended Oct 1, 2016 · USPTO record | Term ended | Term ended Oct 1, 2016 | USPTO record |
| US 7,781,432 | Analogs of Nitrobenzylthioinosine Lapsed on the fee record Ended Aug 24, 2014 · High confidence | Lapsed on the fee record | Ended Aug 24, 2014 | High confidence |
| US 7,364,741 | Peptides of human Papilloma virus for use in human T cell response inducing compositions Formerly held Lapsed on the fee record Ended Apr 29, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2012 | USPTO record |